Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
+62.6K
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$937K
-
Put/Call ratio
-
0.4
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$14.99
Significant Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2013
129 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q4 2013.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 124M outstanding shares and own 64.27% of the company stock.
Largest 10 shareholders include Third Security, LLC (19.8M shares), BAKER BROS. ADVISORS LP (6.3M shares), VANGUARD GROUP INC (5.28M shares), BB Biotech AG (4.72M shares), Sectoral Asset Management Inc (4.7M shares), FMR LLC (4.65M shares), QVT Financial LP (4.22M shares), BlackRock Fund Advisors (3.52M shares), FRANKLIN RESOURCES INC (2.74M shares), and State Street Corp (2.66M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.